skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines durvalumabQuestion & answer

durvalumab · Medicine question

What is the approximate terminal half-life of durvalumab?

iatroX medicinesPublished 8 November 2026

The answer

Answer

The terminal half-life of durvalumab, based on baseline clearance, is approximately 18 days.

Sources for this answer

IMFINZI 50 mg/mL concentrate for solution for infusionAstraZeneca UK Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 38Document updated 6 May 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

durvalumab

More questions about durvalumab

What is the shelf life of an unopened vial of durvalumab (Imfinzi) concentrate for solution for infusion?Can durvalumab (Imfinzi) concentrate for solution for infusion be mixed with other medicinal products in the absence of compatibility studies?Can durvalumab cause immune-mediated colitis or diarrhoea?Can durvalumab cause immune-mediated pneumonitis or interstitial lung disease?Can durvalumab cause type 1 diabetes that first presents as diabetic ketoacidosis?How does durvalumab enhance the immune response against tumours?

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the durvalumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX